EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source

NCT06715449 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Embolic Stroke of Undetermined Source
Atrial Fibrillation New Onset

Interventions

DRUG: Empagliflozin 10 MG

Sponsor

University of East Anglia

Collaborators

[object Object]